{"id":"https://openalex.org/W7225402976","doi":"https://doi.org/10.1080/14796694.2026.2753928","title":"Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05","display_name":"Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225402976","doi":"https://doi.org/10.1080/14796694.2026.2753928","pmid":"https://pubmed.ncbi.nlm.nih.gov/42992631"},"language":"en","primary_location":{"id":"doi:10.1080/14796694.2026.2753928","doi":"https://doi.org/10.1080/14796694.2026.2753928","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14796694.2026.2753928","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753928?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753928?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056565799","display_name":"Veronique C Dieras","orcid":"https://orcid.org/0000-0001-8094-4738","observed_orcids":["https://orcid.org/0000-0001-8094-4738","https://orcid.org/0000-0002-8798-6540"]},"institutions":[{"id":"https://openalex.org/I4210110881","display_name":"Centre Eug\u00e8ne Marquis","ror":"https://ror.org/01yezas83","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210110881"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Veronique Dieras","raw_affiliation_strings":["aMedical Oncology Department, Centre Eug\u00e8ne Marquis, Rennes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aMedical Oncology Department, Centre Eug\u00e8ne Marquis, Rennes, France","institution_ids":["https://openalex.org/I4210110881"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003897511","display_name":"Giuseppe Curigliano","orcid":"https://orcid.org/0000-0003-1781-2518","observed_orcids":["https://orcid.org/0000-0003-1781-2518"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Curigliano","raw_affiliation_strings":["bDepartment of Oncology and Hemato-Oncology, University of Milano, Milano, Italy","cEuropean Institute of Oncology, IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bDepartment of Oncology and Hemato-Oncology, University of Milano, Milano, Italy","institution_ids":["https://openalex.org/I189158943"]},{"raw_affiliation_string":"cEuropean Institute of Oncology, IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161106951","display_name":"Miguel Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2960094004","display_name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/0111es613","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2960094004","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Martin","raw_affiliation_strings":["dMedical Oncology Service, Hospital General Universitario Gregorio Mara\u00f1on, Universidad Complutense, GEICAM, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"dMedical Oncology Service, Hospital General Universitario Gregorio Mara\u00f1on, Universidad Complutense, GEICAM, Madrid, Spain","institution_ids":["https://openalex.org/I2960094004","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112773994","display_name":"Florence Lerebours","orcid":"https://orcid.org/0000-0002-3952-4296","observed_orcids":["https://orcid.org/0000-0002-3952-4296"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Lerebours","raw_affiliation_strings":["eInstitut Curie-Saint Cloud, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eInstitut Curie-Saint Cloud, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012322249","display_name":"Junji Tsurutani","orcid":"https://orcid.org/0000-0002-6260-6943","observed_orcids":["https://orcid.org/0000-0002-6260-6943"]},"institutions":[{"id":"https://openalex.org/I4210160413","display_name":"SHOWA Medical University Hospital","ror":"https://ror.org/04wn7d698","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210160413"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junji Tsurutani","raw_affiliation_strings":["fThe Innovative Center of Translational Research and Clinical Science for Cancer Therapy, Showa Medical University Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"fThe Innovative Center of Translational Research and Clinical Science for Cancer Therapy, Showa Medical University Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210160413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070992620","display_name":"Marie-France Savard","orcid":"https://orcid.org/0000-0002-7651-0870","observed_orcids":["https://orcid.org/0000-0002-7651-0870"]},"institutions":[{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marie-France Savard","raw_affiliation_strings":["gDepartment of Medicine, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"gDepartment of Medicine, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada","institution_ids":["https://openalex.org/I2800722420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057024351","display_name":"Katarzyna Joanna Jerzak","orcid":"https://orcid.org/0000-0002-3995-0308","observed_orcids":["https://orcid.org/0000-0002-3995-0308"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Katarzyna J. Jerzak","raw_affiliation_strings":["hDepartment of Medicine, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"hDepartment of Medicine, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I185261750","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158601283","display_name":"Xichun Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]},{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xichun Hu","raw_affiliation_strings":["iDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"iDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China","institution_ids":["https://openalex.org/I24943067","https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051501469","display_name":"Luciana Carla Martins de Aquino Pimentel","orcid":"https://orcid.org/0000-0002-3638-9746","observed_orcids":["https://orcid.org/0000-0002-3638-9746"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luciana Carla Martins de Aquino Pimentel","raw_affiliation_strings":["jMedical Oncology, Liga Norte-Rio Grandense Contra o Cancer, Natal, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"jMedical Oncology, Liga Norte-Rio Grandense Contra o Cancer, Natal, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058935870","display_name":"Ciara Catherine O'Sullivan","orcid":"https://orcid.org/0000-0001-6069-9800","observed_orcids":["https://orcid.org/0000-0001-6069-9800"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ciara C. O\u2019Sullivan","raw_affiliation_strings":["kDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"kDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011644667","display_name":"Eriko Tokunaga","orcid":"https://orcid.org/0000-0002-1640-5315","observed_orcids":["https://orcid.org/0000-0002-1640-5315"]},"institutions":[{"id":"https://openalex.org/I4210093709","display_name":"National Hospital Organization Kyushu Cancer Center","ror":"https://ror.org/00mce9b34","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093709","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eriko Tokunaga","raw_affiliation_strings":["lDepartment of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"lDepartment of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan","institution_ids":["https://openalex.org/I4210093709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065638223","display_name":"Alicia F. C. Okines","orcid":"https://orcid.org/0000-0002-2068-2593","observed_orcids":["https://orcid.org/0000-0002-2068-2593"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alicia Okines","raw_affiliation_strings":["mMedical Oncology, The Royal Marsden NHS Foundation Trust, London, United Kingdom and Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"mMedical Oncology, The Royal Marsden NHS Foundation Trust, London, United Kingdom and Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161062854","display_name":"Chiun-Sheng Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Chiun-Sheng Huang","raw_affiliation_strings":["nBreast Care Center, National Taiwan University Hospital, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"nBreast Care Center, National Taiwan University Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053668514","display_name":"William Jacot","orcid":"https://orcid.org/0000-0001-7834-061X","observed_orcids":["https://orcid.org/0000-0001-7834-061X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]},{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"William Jacot","raw_affiliation_strings":["oD\u00e9partement d'Oncologie M\u00e9dicale, Institut Regional du Cancer de Montpellier, Montpellier University, INSERM U1194, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"oD\u00e9partement d'Oncologie M\u00e9dicale, Institut Regional du Cancer de Montpellier, Montpellier University, INSERM U1194, Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335","https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030577122","display_name":"Joohyuk Sohn","orcid":"https://orcid.org/0000-0002-2303-2764","observed_orcids":["https://orcid.org/0000-0002-2303-2764"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Joohyuk Sohn","raw_affiliation_strings":["pDivision of Medical Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pDivision of Medical Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152230950","display_name":"Eduardo Cronemberger Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eduardo Cronemberger Silva","raw_affiliation_strings":["qMedical Oncology, Centro Regional Integrado de Oncologia (CRIO), Fortaleza, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"qMedical Oncology, Centro Regional Integrado de Oncologia (CRIO), Fortaleza, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161031336","display_name":"Volkmar Muelle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Volkmar Muelle","raw_affiliation_strings":["rDepartment of Gynecology and University Breast Center, Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"rDepartment of Gynecology and University Breast Center, Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079581626","display_name":"Shan Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan Yang","raw_affiliation_strings":["sBiostatistics, Pfizer Inc, Bothell, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"sBiostatistics, Pfizer Inc, Bothell, WA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063555334","display_name":"G. Granata","orcid":"https://orcid.org/0000-0001-9651-4708","observed_orcids":["https://orcid.org/0000-0001-9651-4708"]},"institutions":[{"id":"https://openalex.org/I4210099786","display_name":"Pfizer (Switzerland)","ror":"https://ror.org/00z8x2k69","country_code":"CH","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210099786"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Giovanna Granata","raw_affiliation_strings":["tOncology Late Stage Development, Pfizer AG, Zug, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"tOncology Late Stage Development, Pfizer AG, Zug, Switzerland","institution_ids":["https://openalex.org/I4210099786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101516601","display_name":"Qi Shen","orcid":"https://orcid.org/0000-0002-3132-5540","observed_orcids":["https://orcid.org/0000-0002-3132-5540"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Shen","raw_affiliation_strings":["uOncology, Research and Development, Pfizer Inc., Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"uOncology, Research and Development, Pfizer Inc., Collegeville, PA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5156929689","display_name":"Erika Hamilton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika Hamilton","raw_affiliation_strings":["vMedical Oncology, Sarah Cannon Research Institute, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"vMedical Oncology, Sarah Cannon Research Institute, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210100810"]}]}],"institutions":[],"countries_distinct_count":12,"institutions_distinct_count":28,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tucatinib","display_name":"tucatinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/her2-positive-metastatic-breast-cancer","display_name":"HER2-positive metastatic breast cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8859999775886536},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6620000004768372},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.6269999742507935},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.6510000228881836},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6489999890327454},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9372000098228455},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.880299985408783},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8414000272750854},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7757999897003174},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7563999891281128},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7038999795913696},{"id":"https://openalex.org/C2777083192","wikidata":"https://www.wikidata.org/wiki/Q1814648","display_name":"Plain language","level":2,"score":0.4309999942779541},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.4212999939918518},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.2922999858856201},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2906000018119812},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.2782999873161316},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.27300000190734863},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.25999999046325684},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2578999996185303}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/14796694.2026.2753928","doi":"https://doi.org/10.1080/14796694.2026.2753928","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14796694.2026.2753928","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753928?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmid:42992631","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42992631","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/14796694.2026.2753928","doi":"https://doi.org/10.1080/14796694.2026.2753928","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14796694.2026.2753928","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753928?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225402976.pdf","grobid_xml":"https://content.openalex.org/works/W7225402976.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4229065760","https://openalex.org/W4379328967","https://openalex.org/W4281757801","https://openalex.org/W4365512785","https://openalex.org/W4396590806","https://openalex.org/W4322772141","https://openalex.org/W4417198347","https://openalex.org/W7162521509","https://openalex.org/W7129265269","https://openalex.org/W4384009545"],"abstract_inverted_index":{"Plain":[0],"Language":[1],"SummaryWhat":[2],"is":[3],"this":[4],"summary":[5,7],"about?This":[6],"describes":[8],"an":[9,264],"article":[10,22],"published":[11],"in":[12,18,52,104],"the":[13,24,36,114,132,154,158,209,219,230,233,271,274,277,282,295],"Journal":[14],"of":[15,26,38,84,194,243,273,281,297],"Clinical":[16],"Oncology":[17],"December":[19],"2025.":[20],"The":[21,192],"reports":[23],"results":[25,278,280],"a":[27,128],"clinical":[28],"trial":[29,320],"called":[30],"HER2CLIMB-05,":[31],"which":[32],"evaluated":[33],"how":[34,112,137],"well":[35,113],"addition":[37],"tucatinib":[39,101,155,172,210,234,288],"to":[40,81,98,135,289],"standard":[41,107,174,189,290],"maintenance":[42,108,175,190,291],"therapy":[43,176,292,313],"(trastuzumab":[44],"and":[45,90,146,212,250,316,318],"pertuzumab)":[46],"stops":[47],"cancer":[48,72,74,121,143,169,181,200,305,309],"from":[49],"getting":[50,144],"worse":[51,78,145],"people":[53,67,164,184,196,231,300],"with":[54,68,88,106,165,171,186,259,301,314],"human":[55],"epidermal":[56],"growth":[57],"factor":[58],"receptor":[59],"2-positive":[60],"(HER2+)":[61],"metastatic":[62,70,167,303],"breast":[63,71,168,304],"cancer.This":[64],"study":[65,161,284],"included":[66,236],"HER2+":[69,166,302],"whose":[73],"did":[75],"not":[76],"get":[77],"after":[79],"4":[80],"8":[82],"treatments":[83,115],"first-line":[85,312],"chemotherapy":[86,315],"combined":[87],"trastuzumab":[89,317],"pertuzumab.":[91],"These":[92,253],"individuals":[93,117,139],"were":[94,118,157,256],"then":[95],"randomly":[96],"assigned":[97],"receive":[99],"either":[100],"or":[102,269],"placebo":[103,187,220],"combination":[105,235],"therapy.":[109,191],"To":[110],"evaluate":[111],"worked,":[116],"monitored":[119],"for":[120],"worsening":[122,182,201,310],"by":[123],"measuring":[124],"tumor":[125],"sites":[126],"on":[127],"regular":[129],"basis.":[130],"Overall,":[131],"researchers":[133],"wanted":[134],"know":[136],"long":[138],"lived":[140,177,197],"without":[141,179,198,307],"their":[142,180,199,308],"what":[147],"side":[148,225,254],"effects":[149,226,255],"could":[150],"happen":[151],"when":[152],"receiving":[153,232],"combination.What":[156],"results?The":[159],"HER2CLIMB-05":[160,283],"showed":[162],"that":[163,227,286,299],"treated":[170,185],"plus":[173,188],"longer":[178],"than":[183],"length":[193,296],"time":[195,298],"was":[202],"24.9":[203],"months":[204,214],"among":[205,215,229],"those":[206,216],"who":[207,217],"received":[208,218],"combination,":[211],"16.3":[213],"combination.The":[221],"most":[222],"frequently":[223],"reported":[224],"occurred":[228],"diarrhea":[237],"(73%),":[238],"nausea":[239],"(33%),":[240],"elevated":[241],"levels":[242],"liver":[244],"enzymes":[245],"(26%\u201328%),":[246],"joint":[247],"pain":[248],"(21%),":[249],"fatigue":[251],"(21%).":[252],"mostly":[257],"manageable":[258],"supportive":[260],"care":[261],"(e.g.,":[262],"taking":[263],"anti-diarrhea":[265],"medication)":[266],"and/or":[267],"lowering":[268],"holding":[270],"dose":[272],"treatment.What":[275],"do":[276],"mean?The":[279],"suggest":[285],"adding":[287],"significantly":[293],"prolongs":[294],"live":[306],"following":[311],"pertuzumab.Clinical":[319],"number:":[321],"NCT05132582":[322]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-07T00:00:00"}